PsychedeLinks is a weekly digest of news, business, and culture in the psychedelics industry curated by members of Emerge Law Group’s groundbreaking Psychedelics Industry Group.
Decriminalization, Legalization, and Other State Efforts
San Francisco Lawmakers Unanimously Approve Psychedelics Decriminalization Resolution
San Francisco lawmakers have unanimously approved a measure calling for the decriminalization of psychedelics like psilocybin and ayahuasca. The Board of Supervisors approved the measure, sponsored by Supervisors Dean Preston (D) and Hillary Ronen (D), on Wednesday. While it doesn’t immediately enac…
Legalizing psychedelic mushrooms is on the Colorado ballot this fall. Here’s what you need to know
If the Natural Medicine Health Act passes, it would no longer be a state crime for people over 21 years old to grow, possess or gift psilocybin mushrooms.
Aspen considers the value of psychedelics for mental wellness
Since 500 BC, humans have been using psychedelics to explore the connection between nature and the divine, to deepen the connection with their community and as a celebration of the natural world.
Psychedelics For Military Veterans Discussed At Missouri House Hearing As GOP Lawmaker Plans To File Reform Bill
Missouri lawmakers held a hearing on Wednesday to discuss possible solutions to the military veterans’ mental health and suicide crisis, with several people testifying about the possible therapeutic potential of psychedelics for the at-risk population. The House Interim Committee on Veterans Mental…
Georgia Lawmakers Talk Next Steps For Psychedelics Research For Military Veterans At Committee Hearing
Georgia lawmakers discussed the therapeutic potential of psychedelics like psilocybin for serious mental health conditions at a hearing focused on military veterans last week. Experts and people with personal experience with psychedelic treatment testified before the House Defense and Veterans Affai…
Mindset Pharma leading the charge to advance psychedelic medicines to treat mental illness
Deep Dive - Mindset Pharma Inc
Canadian Psychedelics Company Reduces Manufacturing Time Of MDMA By Two Thirds
Nirvana Life Sciences Inc. (CSE: NIRV) announced that it has engineered a method that reduces the manufacturing time of MDMA by two thirds.
Is the Psychedelic Therapy Bubble About to Burst?
A new paper argues that excitement has veered into misinformation—and scientists should be the ones to set things straight.
Subscribe to PsychedeLinks to receive essential weekly articles on news, business, and culture in the psychedelics industry, delivered straight to your inbox.
PsychedeLinks by Emerge Law Group
PsychedeLinks is a weekly brief on news, business, and culture in the psychedelics industry curated by members of Emerge Law Group's groundbreaking Psychedelics Industry Group.